Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Siddappa N Byrareddy, Kalicharan Sharma, Shrikesh Sachdev, Athreya S. Reddy, Arpan Acharya, Kaylee M. Klaustermeier, Christian L Lorson & Kamal Singh. (2023) Potential therapeutic targets for Mpox: the evidence to date. Expert Opinion on Therapeutic Targets 27:6, pages 419-431.
Read now
Read now
Wen Li, Lu Lu, Weihua Li & Shibo Jiang. (2017) Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015). Expert Opinion on Therapeutic Patents 27:6, pages 707-719.
Read now
Read now
Michelle B. Kim, Kyle E. Giesler, Yesim A. Tahirovic, Valarie M. Truax, Dennis C. Liotta & Lawrence J. Wilson. (2016) CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. Expert Opinion on Investigational Drugs 25:12, pages 1377-1392.
Read now
Read now
Jetske M Emmelkamp & Jürgen K Rockstroh. (2008) Maraviroc, risks and benefits: a review of the clinical literature. Expert Opinion on Drug Safety 7:5, pages 559-569.
Read now
Read now
Articles from other publishers (35)
Lu Sun, Peng Nie, Li Luan, Piet Herdewijn & Ya-Tao Wang. (2023) Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update. European Journal of Medicinal Chemistry 261, pages 115847.
Crossref
Crossref
Li Zhao & Yu Lai. (2023) Monoclonal CCR5 Antibody: A Promising Therapy for HIV. Current HIV Research 21:2, pages 91-98.
Crossref
Crossref
Daniel Łowicki & Piotr Przybylski. (2022) Tandem construction of biological relevant aliphatic 5-membered N-heterocycles. European Journal of Medicinal Chemistry 235, pages 114303.
Crossref
Crossref
Neelima Shrivastava, Asif Husain, Mohammad Rashid, Nimer Fehaid Alsabeelah, Shahid Karim & Nasir Ali Siddiqui. (2021) Recent Advances Towards Treatment of HIV: Synthesis and SAR Studies. Mini-Reviews in Medicinal Chemistry 21:4, pages 471-499.
Crossref
Crossref
Sindhuri Upadrasta & Vikas Yadav. 2021. Translational Biotechnology. Translational Biotechnology
347
369
.
Raquel Fernández-García, María Prada, Francisco Bolás-Fernández, M. Paloma Ballesteros & Dolores R. Serrano. (2020) Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing. Pharmaceutical Research 37:7.
Crossref
Crossref
Koree W. Ahn & Michael J. Root. (2017) Complex interplay of kinetic factors governs the synergistic properties of HIV-1 entry inhibitors. Journal of Biological Chemistry 292:40, pages 16498-16510.
Crossref
Crossref
Borja Mora-Peris, Alan Winston, Lucy Garvey, Laura J. Else, Robin J. Shattock & Carolina Herrera. (2016)
HIV-1 CNS
in vitro
infectivity models based on clinical CSF samples
. Journal of Antimicrobial Chemotherapy 71:1, pages 235-243.
Crossref
Crossref
Francesca Curreli, Kashfia Haque, Lihua Xie, Qian Qiu, Jinfeng Xu, Weizhong Yong, Xiaohe Tong & Asim K. Debnath. (2015) Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor. Bioorganic & Medicinal Chemistry 23:24, pages 7618-7628.
Crossref
Crossref
Katie M. Kilgore, Megan K. Murphy, Samantha L. Burton, Katherine S. Wetzel, S. Abigail Smith, Peng Xiao, Sharmila Reddy, Nicholas Francella, Donald L. Sodora, Guido Silvestri, Kelly S. Cole, Francois Villinger, James E. Robinson, Bali Pulendran, Eric Hunter, Ronald G. Collman, Rama R. Amara & Cynthia A. Derdeyn. (2015) Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope. Journal of Virology 89:16, pages 8130-8151.
Crossref
Crossref
Rohit Bhat, Amna T. Adam, Jungeun Jasmine Lee, Gaspard Deloison, Yves Rouillé, Karin Séron & David P. Rotella. (2014) Structure–activity studies of (−)-epigallocatechin gallate derivatives as HCV entry inhibitors. Bioorganic & Medicinal Chemistry Letters 24:17, pages 4162-4165.
Crossref
Crossref
M. Chilukuri, K. Hussainreddy, P. Narayanareddy & M. Venkataramana. (2013) A Validated Stability-Indicating UPLC Method for the Determination of Impurities in Maraviroc. Journal of Chromatographic Science 52:7, pages 609-616.
Crossref
Crossref
Lun Li, Jin Hui Tian, KeHu Yang, Peng Zhang & Wen Qin Jia. (2014) Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jianguo Liang, Jianping Chen, Zhiwu Tan, Jie Peng, Xiao Zheng, Kenji Nishiura, Jenny Ng, Zhiyu Wang, Dongmei Wang, Zhiwei Chen & Li Liu. (2013) Extracts of the medicinal herb Sanguisorba officinalis inhibit the entry of human immunodeficiency virus-1. Journal of Food and Drug Analysis 21:4, pages S52-S58.
Crossref
Crossref
Kongtian Wu, Xiaochang Xue, Meng Li, Xin Qin, Cun Zhang, Weina Li, Qiang Hao, Zenglu Wang, Qian Liu, Wei Zhang & Yingqi Zhang. (2013) High level expression, purification and characterization of recombinant CCR5 as a vaccine candidate against HIV. Protein Expression and Purification 89:2, pages 124-130.
Crossref
Crossref
Deron R. Herr. 2012. International Review of Cell and Molecular Biology Volume 297. International Review of Cell and Molecular Biology Volume 297
45
81
.
Haishan Li & C. David Pauza. (2011) HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS. Blood 118:22, pages 5824-5831.
Crossref
Crossref
Craig B. Wilen, Nicholas F. Parrish, Jennifer M. Pfaff, Julie M. Decker, Elizabeth A. Henning, Hillel Haim, Josiah E. Petersen, Jason A. Wojcechowskyj, Joseph Sodroski, Barton F. Haynes, David C. Montefiori, John C. Tilton, George M. Shaw, Beatrice H. Hahn & Robert W. Doms. (2011) Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins. Journal of Virology 85:17, pages 8514-8527.
Crossref
Crossref
Viktor O. Iaroshenko, Verena Specowius, Katharina Vlach, Marcelo Vilches-Herrera, Dmytro Ostrovskyi, Satenik Mkrtchyan, Alexander Villinger & Peter Langer. (2011) A general strategy for the synthesis of difluoromethyl-containing pyrazoles, pyridines and pyrimidines. Tetrahedron 67:31, pages 5663-5677.
Crossref
Crossref
F. Charles Brunicardi, Richard A. Gibbs, David A. Wheeler, John Nemunaitis, William Fisher, John Goss & Changyi Chen. (2011) Overview of the Development of Personalized Genomic Medicine and Surgery. World Journal of Surgery 35:8, pages 1693-1699.
Crossref
Crossref
Zhicheng Zhou, Nicolas Barry de Longchamps, Alain Schmitt, Marc Zerbib, Marie-Cécile Vacher-Lavenu, Morgane Bomsel & Yonatan Ganor. (2011) HIV-1 Efficient Entry in Inner Foreskin Is Mediated by Elevated CCL5/RANTES that Recruits T Cells and Fuels Conjugate Formation with Langerhans Cells. PLoS Pathogens 7:6, pages e1002100.
Crossref
Crossref
Lun Li, TianTian Sun, KeHu Yang, Peng Zhang & Wen Qin Jia. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Nicola J. Smith & Graeme Milligan. (2010) Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes. Pharmacological Reviews 62:4, pages 701-725.
Crossref
Crossref
Jianhui Nie, Chuntao Zhang, Wei Liu, Xueling Wu, Feng Li, Suting Wang, Fuxiong Liang, Aijing Song & Youchun Wang. (2010) Genotypic and Phenotypic Characterization of HIV-1 CRF01_AE env Molecular Clones From Infections in China. JAIDS Journal of Acquired Immune Deficiency Syndromes 53:4, pages 440-450.
Crossref
Crossref
Lun Li, KeHu Yang, KeHu Yang, TianTian Sun, Peng Zhang & Wen Qin Jia. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Frank Romanelli. 2010. Management of Antimicrobials in Infectious Diseases. Management of Antimicrobials in Infectious Diseases
327
342
.
Birgitt Dau & Mark Holodniy. (2009) Novel Targets for Antiretroviral Therapy. Drugs 69:1, pages 31-50.
Crossref
Crossref
Erhard Kopetzki, Andreas Jekle, Changhua Ji, Eileen Rao, Jun Zhang, Stephan Fischer, Nick Cammack, Surya Sankuratri & Gabrielle Heilek. (2008) Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1. Virology Journal 5:1.
Crossref
Crossref
Aviva Lapidot, Alexander Berchanski & Gadi Borkow. (2008) Insight into the mechanisms of aminoglycoside derivatives interaction with HIV‐1 entry steps and viral gene transcription. The FEBS Journal 275:21, pages 5236-5257.
Crossref
Crossref
Sharon S. Lieberman-Blum, Horatio B. Fung & Juan C. Bandres. (2008) Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection. Clinical Therapeutics 30:7, pages 1228-1250.
Crossref
Crossref
Catherine S. Adamson & Eric O. Freed. (2008) Recent progress in antiretrovirals – lessons from resistance. Drug Discovery Today 13:9-10, pages 424-432.
Crossref
Crossref
Jacob Lalezari, Gopal K. Yadavalli, Michael Para, Gary Richmond, Edwin DeJesus, Stephen J. Brown, Wendy Cai, Cecil Chen, John Zhong, Lu Anne Novello, Michael M. Lederman & G. Mani Subramanian. (2008) Safety, Pharmacokinetics, and Antiviral Activity of HGS004, a Novel Fully Human IgG4 Monoclonal Antibody against CCR5, in HIV‐1–Infected Patients. The Journal of Infectious Diseases 197:5, pages 721-727.
Crossref
Crossref
Graeme Milligan & Nicola J. Smith. (2007) Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends in Pharmacological Sciences 28:12, pages 615-620.
Crossref
Crossref
Andrew P RiceRichard E Sutton. (2007) Targeting protein–protein interactions for HIV therapeutics. Future HIV Therapy 1:4, pages 369-385.
Crossref
Crossref
Richard E Sutton. (2007) What does the future hold for viral gene therapy?. Future Virology 2:6, pages 543-547.
Crossref
Crossref